Effect of dietary resveratrol on the metabolic profile of nutrients in obese OLETF rats

Lipids in Health and Disease

Volumn 12, Issue 1, 2013, Pages

  Nagao, Koji ^a   Jinnouchi, Tomoyuki ^a   Kai, Shunichi ^a   Yanagita, Teruyoshi ^a,b  

^a SAGA UNIVERSITY   (Japan)

^b NISHIKYUSHU UNIVERSITY   (Japan)

Author keywords

Metabolic profile; Obesity; OLETF rat; Respiratory gas analysis; Resveratrol

Indexed keywords

AIN 76; CARBOHYDRATE; CARNITINE PALMITOYLTRANSFERASE; LIPID; MESSENGER RNA; PROTEIN; RESVERATROL; UNCLASSIFIED DRUG;

ABDOMEN; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD GAS ANALYSIS; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG MECHANISM; FAT INTAKE; FEEDING; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPID STORAGE; LIVER; LUNG GAS EXCHANGE; MALE; METABOLIC PARAMETERS; NON HIGH FAT INTAKE; NONHUMAN; NUTRIENT; OBESITY; PATHOGENESIS; RAT; SERUM; TREATMENT DURATION; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE, WHITE; ANIMALS; BODY WEIGHT; CARNITINE O-PALMITOYLTRANSFERASE; CHOLESTEROL; FOOD, FORMULATED; GENE EXPRESSION; GLYCOGEN; LIPID METABOLISM; LIVER; MALE; METABOLOME; OBESITY; RATS; RATS, INBRED OLETF; RNA, MESSENGER; STILBENES; TRIGLYCERIDES; UP-REGULATION;

RATTUS; VITACEAE;

EID: 84873166918     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-12-8     Document Type: Article

References (32)

1. Regional adiposity and morbidity. Kissebah AH, Krakower GR, Physiol Rev 1994 74 761 811 7938225
2. The disease burden associated with overweight and obesity. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Detz WH, JAMA 1999 282 1523 1529 10.1001/jama.282.16.1523 10546691
3. Obesity and target organ damage: diabetes. Adler A, Int J Obes Relat Metab Disord 2002 26 11 S14 10.1038/sj.ijo.0802212 12457293
4. Prevalence and trends in obesity among U.S. adults 1999-2000. Fiegal KM, Carroll MD, Ogden CL, Johnson CL, AMA 2002 288 1723 1727 10.1001/jama.288.14. 1723
5. The medical risks of obesity. Pi-Sunyer FX, Obes Surg 2002 12 6 S11 10.1381/096089202762552601
6. Polyphenols and prevention of cardiovascular diseases. Manach C, Mazur A, Scalbert A, Curr Opin Lipidol 2005 16 77 84 10.1097/00041433-200502000-00013 15650567
7. Mukitake mushroom (Panellus serotinus) alleviates nonalcoholic fatty liver disease through the suppression of monocyte chemoattractant protein-1 production in db/db mice. Nagao K, Inoue N, Inafuku M, Shirouchi B, Morooka T, Nomura S, Nagamori N, Yanagita T, J Nutr Biochem 2010 21 418 423 10.1016/j.jnutbio.2009.01.021 19423319
8. Protective effects of fractional extracts from Panellus serotinus on nonalcoholic fatty liver disease in obese, diabetic db/db mice. Inafuku M, Nagao K, Nomura S, Shirouchi B, Inoue N, Nagamori N, Nakayama H, Toda T, Yanagita T, Br J Nutr 2012 107 639 646 10.1017/S0007114511003485 21787451
9. Effects of citrus auraptene (7-geranyloxycoumarin) on hepatic lipid metabolism in vitro and in vivo. Nagao K, Yamano N, Shirouchi B, Inoue N, Murakami S, Sasaki T, Yanagita T, J Agric Food Chem 2010 58 9028 9032 10.1021/jf1020329
10. Polyphenolic extract of lotus root (edible rhizome of Nelumbo nucifera) alleviates hepatic steatosis in obese diabetic db/db mice. Tsuruta Y, Nagao K, Kai S, Yoshimura T, Tsuge K, Koganemaru K, Yanagita T, Lipids Health Dis 2011 10 202 10.1186/1476-511X-10-202 22067945
11. Resveratrol and its analogues: promising antitumor agents. Huang X, Zhu HL, Anticancer Agents Med Chem 2011 11 479 490 10.2174/187152011795677427 21524243
12. Resveratrol ameliorates diabetes-related metabolic changes via activation of AMP-activated protein kinase and its downstream targets in db/db mice. Do GM, Jung UJ, Park HJ, Kwon EY, Jeon SM, McGregor RA, Choi MS, Mol Nutr Food Res 2012 56 1282 1291 10.1002/mnfr.201200067 22715031
13. Resveratrol attenuates steatosis in obese Zucker rats by decreasing fatty acid availability and reducing oxidative stress. Gómez-Zorita S, Fernández-Quintela A, Macarulla MT, Aguirre L, Hijona E, Bujanda L, Milagro F, Martínez JA, Portillo MP, Cardiovasc Br J Nutr 2012 107 202 210 10.1017/S0007114511002753
14. Resveratrol exerts anti-obesity effects via mechanisms involving down-regulation of adipogenic and inflammatory processes in mice. Kim S, Jin Y, Choi Y, Park T, Biochem Pharmacol 2011 81 1343 1351 10.1016/j.bcp.2011.03.012 21439945
15. Changes in white adipose tissue metabolism induced by resveratrol in rats. Alberdin G, Rodríguez VM, Miranda J, Macarulla MT, Arias N, Andrés-Lacueva C, Portillo MP, Nutr Metab 2011 8 29 10.1186/1743-7075-8- 29
16. The 10trans,12cis isomer of conjugated linoleic acid suppresses the development of hypertension in Otsuka Long-Evans Tokushima fatty rats. Nagao K, Inoue N, Wang YM, Hirata J, Shimada Y, Nagao T, Matsui T, Yanagita T, Biochem Biophys Res Commun 2003 306 134 138 10.1016/S0006-291X(03)00929-X 12788078
17. Dietary effect of pomegranate seed oil rich in 9cis,11trans,13cis conjugated linolenic acid on lipid metabolism in obese, hyperlipidemic OLETF Rats. Arao K, Wang YM, Inoue N, Hirata J, Cha JY, Nagao K, Yanagita T, Lipids Health Dis 2004 3 24 10.1186/1476-511X-3-24 15533261
18. Isomer-specific anti-obese and hypolipidemic properties of conjugated linoleic acid in obese OLETF rats. Wang YM, Nagao K, Inoue N, Ujino Y, Shimada Y, Nagao T, Iwata T, Kamegai T, Yamauchi-Sato Y, Yanagita T, Biosci Biotechnol Biochem 2006 70 355 362 10.1271/bbb.70.355 16495650
19. Effect of dietary omega 3 phosphatidylcholine on obesity-related disorders in obese Otsuka Long-Evans Tokushima Fatty rats. Shirouchi B, Nagao K, Inoue N, Ohkubo T, Hibino H, Yanagita T, J Agric Food Chem 2007 55 7170 7176 10.1021/jf071225x 17661494
20. Screening of soy protein-derived hypotriglyceridemic di-peptides in vitro and in vivo. Inoue N, Nagao K, Sakata K, Yamano N, Gunawardena ERP, Han SY, Matsui T, Nakamori T, Furuta H, Takamatsu K, Yanagita T, Lipids Health Dis 2011 10 85 10.1186/1476-511X-10-85 21600040
21. Effect of Vaccinium ashei reade leaf extracts on lipid metabolism in obese OLETF rats. Inoue N, Nagao N, Nomura S, Shirouchi B, Inafuku M, Hirabaru H, Nakahara N, Nishizono S, Tanaka T, Yanagita T, Biosci Biotechnol Biochem 2011 75 2304 2308 10.1271/bbb.110451 22146710
22. Dietary phosphatidylinositol prevents the development of nonalcoholic fatty liver disease in Zucker (fa/fa) rats. Shirouchi B, Nagao K, Inoue N, Furuya K, Koga S, Matsumoto H, Yanagita T, J Agric Food Chem 2008 56 2375 2379 10.1021/jf703578d 18324772
23. Determination of glycogen in small tissue samples. Lo S, Russell JC, Taylor AW, J Appl Physiol 1970 28 234 236 5413312
24. The 10trans,12cis isomer of conjugated linoleic acid promotes energy metabolism in OLETF rats. Nagao K, Wang YM, Inoue N, Han SY, Buang Y, Noda T, Kouda N, Okamatsu H, Yanagita T, Nutrition 2003 19 652 656 10.1016/S0899- 9007(03)00060-1 12831953
25. Campest-5-en-3-one, an oxidized derivative of campesterol, activates PPARα, promotes energy consumption and reduces visceral fat deposition in rats. Ikeda I, Konno R, Shimizu T, Ide T, Takahashi N, Kawada T, Nagao K, Inoue N, Yanagita T, Hamada T, Morinaga Y, Tomoyori H, Imaizumi K, Suzuki K, Biochim Biophys Acta 2006 1760 800 807 10.1016/j.bbagen.2006.02.017 16616424
26. Bioactive lipids in metabolic syndrome. Nagao K, Yanagita T, Prog Lipid Res 2008 47 127 146 10.1016/j.plipres.2007.12.002 18177744
27. Medium-chain fatty acids: Functional lipids for the prevention and treatment of the metabolic syndrome. Nagao K, Yanagita T, Pharm Res 2010 61 208 212 10.1016/j.phrs.2009.11.007
28. Fat adaptation in well-trained athletes: effects on cell metabolism. Yeo WK, Carey AL, Burke L, Spriet LL, Hawley JA, Physiol Nutr Metab 2011 36 12 22 10.1139/H10-089
29. Fat adaptation followed by carbohydrate restoration increases AMPK activity in skeletal muscle from trained humans. Yeo WK, Lessard SJ, Chen ZP, Garnham AP, Burke LM, Rivas DA, Kemp BE, Hawley JA, J Appl Physiol 2008 105 1519 1526 10.1152/japplphysiol.90540.2008 18801964
30. Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders. Viollet B, Foretz M, Guigas B, Horman S, Dentin R, Bertrand L, Hue L, Andreelli F, J Physiol 2006 574 41 53 10.1113/jphysiol.2006.108506 16644802
31. Resveratrol inhibits MMP-9 expression by up-regulating PPAR α expression in an oxygen glucose deprivation-exposed neuron model. Cheng G, Zhang X, Gao D, Jiang X, Dong W, Neurosci Lett 2009 451 105 108 10.1016/j.neulet. 2008.12.045 19135132
32. Repeated and long-term treatment with physiological concentrations of resveratrol promotes NO production in vascular endothelial cells. Takahashi S, Nakashima Y, Br J Nutr 2012 107 774 780 10.1017/S0007114511003588 21791144